Emgality

Product manufactured by Eli Lilly And Company

Application Nr Approved Date Route Status External Links
BLA761063 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Emgality ® Is A Calcitonin-Gene Related Peptide Antagonist Indicated In Adults For The: Preventive Treatment Of Migraine. ( 1.1 ) Treatment Of Episodic Cluster Headache. ( 1.2 ) 1.1 Migraine Emgality Is Indicated For The Preventive Treatment Of Migraine In Adults. 1.2 Episodic Cluster Headache Emgality Is Indicated For The Treatment Of Episodic Cluster Headache In Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Galcanezumab

Comments